PHIO PHARMACEUTICALS CORP. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-03-05: Form 10-K; Period of report 2025-12-31; Description FORM 10-K; Document phio20251231_10k.htm.
- 2025-03-31: Form 10-K; Period of report 2024-12-31; Description FORM 10-K FOR DEC 2024; Document phio_i10k-123124.htm.
- 2024-04-01: Form 10-K; Period of report 2023-12-31; Description 10-K FOR 12/31/23; Document phio_i10k-123123.htm.
- 2023-03-22: Form 10-K; Period of report 2022-12-31; Description FORM 10-K; Document phio_i10k-123122.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-03-05 | 10-K | 2025-12-31 | FORM 10-K | phio20251231_10k.htm |
| 2025-03-31 | 10-K | 2024-12-31 | FORM 10-K FOR DEC 2024 | phio_i10k-123124.htm |
| 2024-04-01 | 10-K | 2023-12-31 | 10-K FOR 12/31/23 | phio_i10k-123123.htm |
| 2023-03-22 | 10-K | 2022-12-31 | FORM 10-K | phio_i10k-123122.htm |
| 2022-03-22 | 10-K | 2021-12-31 | FORM 10-K | phio_i10k-123121.htm |
| 2021-03-25 | 10-K | 2020-12-31 | FORM 10-K | phio_10k-123120.htm |
| 2020-03-26 | 10-K | 2019-12-31 | FORM 10-K | phio_10k-123119.htm |
| 2019-03-27 | 10-K | 2018-12-31 | FORM 10-K | phio_10k-123118.htm |
| 2018-03-26 | 10-K | 2017-12-31 | FORM 10-K | d488401d10k.htm |
| 2017-03-30 | 10-K | 2016-12-31 | FORM 10-K | d325199d10k.htm |
| 2016-03-30 | 10-K | 2015-12-31 | FORM 10-K | d108245d10k.htm |
| 2015-03-30 | 10-K | 2014-12-31 | FORM 10-K | d856407d10k.htm |
| 2014-03-28 | 10-K | 2013-12-31 | 10-K | d667381d10k.htm |
| 2013-03-29 | 10-K | 2012-12-31 | FORM 10-K | d461259d10k.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |